Persistent Asset Partners Ltd

Position in RVMD — Revolution Medicines, Inc.

CIK 2056052 HONG KONG, K3

Back to RVMD Full portfolio

Position in RVMD

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,532,681

+$1,135,860 QoQ

Shares Held

26,043

+48.5% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

1.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$30,827

PutShares

317

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Persistent Asset Partners Ltd holds $59,094,384 across 109 Biotechnology names. RVMD ranks #5 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	133,066	$4,329,967
2	COGT	Cogent Biosciences, Inc.	92,516	$3,560,940
3	JAZZ	Jazz Pharmaceuticals plc	15,905	$3,006,840
4	ABVX	Abivax S.A.	22,838	$2,543,011
5	RVMD	Revolution Medicines, Inc. This page	26,043	$2,532,681
6	TERN	Terns Pharmaceuticals, Inc.	45,953	$2,422,642
7	BMRN	Biomarin Pharmaceutical Inc	37,472	$2,116,793
8	KOD	Kodiak Sciences Inc.	51,336	$1,956,928

All Filings in RVMD

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,827	317	-98.8%	Put	Sole	2026-05-12
2026-03-31	$2,532,681	26,043	+48.5%	Shares	Sole	2026-05-12
2025-12-31	$1,396,821	17,537	+28.7%	Shares	Sole	2026-02-17
2025-09-30	$636,380	13,627	-25.3%	Shares	Sole	2026-01-15
2025-06-30	$671,012	18,239	—	Shares	Sole	2025-08-11
No filing history on record for this holder in this stock.